Low immune response to hepatitis B vaccine among children in Dakar, Senegal

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Rey Cuille, Marie Anne ^a,b   Seck, Abdoulaye ^c   Njouom, Richard ^d   Chartier, Loïc ^a   Sow, Housseyn Dembel ^e   MamadouBa, ^e   Ka, Amadou Sidy ^f   Njankouo, Mohamadou ^d   Rousset, Dominique ^d   Giles Vernick, Tamara ^a   Unal, Guillemette ^a   Sire, Jean Marie ^c,g   Garin, Benoît ^c   Simon, François ^g   Vray, Muriel ^a,h  

^a INSTITUT PASTEUR   (France)

^b Centre Nationale de la Recherche Scientifique Institut des Sciences Biologiques   (France)

^c INSTITUT PASTEUR DE DAKAR   (Senegal)

^d CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^e Hopital d'Enfants Albert Royer Dakar   (Senegal)

^f HÔPITAL PRINCIPAL DE DAKAR   (Senegal)

^g SAINT LOUIS HOSPITAL   (France)

^h INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; UNCLASSIFIED DRUG; ZILBRIX;

ANEMIA; ANTIBODY DETECTION; ARTICLE; CAMEROON; CHILD; CONTROLLED STUDY; CONVULSION; CROSS-SECTIONAL STUDY; DIPHTHERIA; DRUG RESPONSE; FEMALE; GASTROINTESTINAL INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFECTION; INFLUENZA B; MAJOR CLINICAL STUDY; MALARIA; MALE; MALNUTRITION; NUTRITIONAL STATUS; PERTUSSIS; PRESCHOOL CHILD; PREVALENCE; RESPIRATORY TRACT DISEASE; RISK FACTOR; SENEGAL; TETANUS; IMMUNOLOGY; INFANT; STATISTICS; VACCINATION;

HAEMOPHILUS INFLUENZAE SEROTYPE B; HEPATITIS B VIRUS;

CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFANT; MALE; SENEGAL; VACCINATION;

EID: 84861601598     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038153     Document Type: Article

References (23)

1. Andre F, (2000) Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 18 (Suppl 1): S20-22.
2. Lavanchy D, (2005) Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 34 (Suppl 1): S1-3.
3. Coursaget P, Deciron F, Tortey E, Barin F, Chiron JP, et al. (1984) Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal). IARC Sci Publ pp. 319-335.
4. Aspinall S, Kocks DJ, (1998) Immunogenicity of a low-cost hepatitis B vaccine in the South African Expanded Programme on Immunisation. S Afr Med J 88: 36-39.
5. Gatchalian S, Reyes M, Bernal N, Lefevre I, David MP, et al. (2005) A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth. Hum Vaccin 1: 198-203.
6. Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, et al. (2001) The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine 19: 3919-3926.
7. WHO, (1991) WHO expanded Programme on Immunisation. Report of the 14th global Advisory Group.: WHO/EPI/GEN/ 92.91.
8. Vray M, Debonne JM, Sire JM, Tran N, Chevalier B, et al. (2006) Molecular epidemiology of hepatitis B virus in Dakar, Senegal. J Med Virol 78: 329-334.
9. Sall Diallo A, Sarr M, Fall Y, Diagne C, Kane MO, (2004) [Hepatitis B infection in infantile population of Senegal]. Dakar Med 49: 136-142.
10. Roingeard P, Diouf A, Sankale JL, Boye C, Mboup S, et al. (1993) Perinatal transmission of hepatitis B virus in Senegal, west Africa. Viral Immunol 6: 65-73.
11. Foupouapouognigni Y, Mba SA, Betsem a Betsem E, Rousset D, Froment A, et al. (2011) Hepatitis B and C virus infections in the three Pygmy groups in Cameroon. J Clin Microbiol 49: 737-740.
12. Chiaramonte M, Stroffolini T, Ngatchu T, Rapicetta M, Lantum D, et al. (1991) Hepatitis B virus infection in Cameroon: a seroepidemiological survey in city school children. J Med Virol 33: 95-99.
13. Garrigue G, Merlin M, Durand JP, Josse R, Kollo B, et al. (1985) [Prevalence of markers of viral hepatitis B in northern Cameroon]. Bull Soc Pathol Exot Filiales 78: 883-889.
14. Kanra G Fau- Kara A, Kara A Fau- Demiralp O, Demiralp O Fau- Contorni M, Contorni M Fau- Hilbert AK, Hilbert Ak Fau- Spyr C, et al. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants.
15. Plotkin SA, Orenstein WA, Offit PA, (2008) Vaccines: Elsevier-Saunders.
16. Wamukonya N, (2005) Power sector reforms in sub-Saharan Africa: some lessons. Economic and Political Weekly 40: 5302-5308.
17. WHO, (2010) Immunization standards, Vaccine quality. 5 Available: http://www.who.int/immunization_standards/vaccine_quality/quinvaxem_shipment_nov10/en/. Accessed: 2012, May.
18. Dao H, Delisle H, Fournier P, (1992) Anthropometric status, serum prealbumin level and immune response to measles vaccination in Mali children. J Trop Pediatr 38: 179-184.
19. el-Gamal Y, Aly RH, Hossny E, Afify E, el-Taliawy D, (1996) Response of Egyptian infants with protein calorie malnutrition to hepatitis B vaccination. J Trop Pediatr 42: 144-145.
20. Lakshmi G, Reddy RP, Kumar KK, Bhavani NV, Dayanand M, (2000) Study of the safety, immunogenicity and seroconversion of a hepatitis-B vaccine in malnourished children of India. Vaccine 18: 2009-2014.
21. Moore SE, Goldblatt D, Bates CJ, Prentice AM, (2003) Impact of nutritional status on antibody responses to different vaccines in undernourished Gambian children. Acta Paediatr 92: 170-176.
22. WHO, (2010) Immunization surveillance, assessment and monitoring. 5 Available: http://www.who.int/immunization_monitoring/en/. Accessed: 2012, May.
23. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, et al. (2002) 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11: 1-190.